Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 12 (10) , 817-821
- https://doi.org/10.1016/0145-2126(88)90035-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Consolidation therapy without maintenance for acute non‐lymphoblastic leukaemiaThe Medical Journal of Australia, 1988
- Day 4 bone marrow aspirate for prediction of resistance to induction chemotherapy in acute myeloid leukemiaLeukemia Research, 1987
- Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurementsBritish Journal of Haematology, 1986
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985
- Prediction of response of acute nonlymphocytic leukaemia to therapy with ‘high dose’ cytosine arabinosideBritish Journal of Haematology, 1984
- Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: Utility of day 6 bone marrow biopsyLeukemia Research, 1983
- Failure of remission induction in acute myelocytic leukemiaMedical and Pediatric Oncology, 1978